Bionomics Investor Presentation Deck
The Mechanism and Pharmacology of BNC210 Demonstrate its Advantages over Current
Therapies for Anxiety Disorders and PTSD*
SSRIs &
SNRIS 1
BZDs ²
(Off-label)
BNC210
Fast Onset of
Action
X
✓
✓
Not
Sedating
✓
X
✓
No Withdrawal/ No Memory
Abuse Potential Impairment
✓
X
X
✓
X
✓
No Motor
Impairment
✓
X
✓
* Potential benefits based on analysis of data from separate studies and not on results that might have been obtained from head-to-head studies. Such data may not be directly
Bionomics comparable due to differences in study protocols, conditions and patient populations. Accordingly, cross-trial comparisons may not be reliable predictors of the relative efficacy or
other benefits of BNC210 compared to existing therapies or other product candidates that may be approved or are in development for the treatment of PTSD or SAD.
1. Includes Valium and certain other benzodiazepines
2. Includes Prozac and certain other SSRIs (Selective Serotonin Reuptake Inhibitors) / SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
No Suicidal
Ideation
X
✓
✓
7
8View entire presentation